[HTML][HTML] Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by
synovitis as the most common clinical manifestation, and interstitial lung disease (RA-ILD) …
synovitis as the most common clinical manifestation, and interstitial lung disease (RA-ILD) …
[HTML][HTML] A multidisciplinary approach to the diagnosis of antisynthetase syndrome
M Wells, S Alawi, KYM Thin, H Gunawardena… - Frontiers in …, 2022 - frontiersin.org
Antisynthetase syndrome is a subtype of idiopathic inflammatory myopathy, strongly
associated with the presence of interstitial lung disease. Diagnosis is made by identifying …
associated with the presence of interstitial lung disease. Diagnosis is made by identifying …
Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements
M Kuwana, M Bando, Y Kawahito, S Sato… - Expert Review of …, 2023 - Taylor & Francis
Background Interstitial lung disease (ILD) is a common complication of connective tissue
diseases (CTD), but there are few clinical trials to guide disease management. We aimed to …
diseases (CTD), but there are few clinical trials to guide disease management. We aimed to …
[HTML][HTML] Progressive fibrosing interstitial lung disease: from bench to bedside
Pulmonary fibrosis is a debilitating and potentially progressive lung disease characterized
by the excessive accumulation of fibrotic tissue within the lung parenchyma, leading to …
by the excessive accumulation of fibrotic tissue within the lung parenchyma, leading to …
[PDF][PDF] Chest high-resolution computed tomography in primary Sjögren's syndrome: An up-to-date primer for rheumatologists
L Cereser, I Giovannini, G Caronia… - Clin. Exp …, 2022 - clinexprheumatol.org
Pulmonary manifestations, including airway involvement and interstitial lung disease, are
the most frequent extra-glandular complications of primary Sjögren's syndrome (pSS). Chest …
the most frequent extra-glandular complications of primary Sjögren's syndrome (pSS). Chest …
Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease
Z Junfei, G Meihua, Z Shuai, L Xiangting, L Zhidan… - Clinical …, 2023 - Springer
The oral Janus kinases inhibitor (JAKi) has improved the management of skin
manifestations in systemic sclerosis (SSc), and our study aimed to explore the efficacy of …
manifestations in systemic sclerosis (SSc), and our study aimed to explore the efficacy of …
Clinical Study of Tofacitinib in the Treatment of Systemic Sclerosis Complicated with Interstitial Lung Disease
TS Chu - papers.ssrn.com
Objective: There have no efficient disease modifying drugs in scleroderma-associated
interstitial lung disease (SSc-ILD) to date, and in this study, we planned to explore the …
interstitial lung disease (SSc-ILD) to date, and in this study, we planned to explore the …